STOCK TITAN

Amerant Bancorp Inc SEC Filings

AMTB NYSE

Welcome to our dedicated page for Amerant Bancorp SEC filings (Ticker: AMTB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Amerant Bancorp Inc. filings document the formal disclosures of a Florida bank holding company with Amerant Bank, N.A. and Amerant Investments, Inc. Recent Form 8-K reports furnish quarterly and annual results, Regulation FD investor presentations, earnings materials, credit and asset-quality updates, and material agreements.

The company’s proxy materials and governance filings cover director elections, board composition, executive compensation, equity-award tables, shareholder meeting matters, officer transitions and compensatory arrangements. These records also disclose bank operating topics such as loan quality, funding mix, liquidity, capital position and balance-sheet management.

Rhea-AI Summary

Amerant Bancorp Inc. released an investor presentation outlining its strategy, 2026 outlook, and recent capital actions. As of March 31, 2026, the bank reported $9.9 billion in assets, $7.9 billion in deposits, and $3.4 billion in assets under management and custody.

The company projects total loans of about $7 billion by 2Q26 and cumulative loan growth of around 7% in 2026, with deposits expected to reach $8 billion in 2Q26 and grow 8–10% for the year. Updated net interest margin is expected at 3.45%–3.50% in 2Q26 and to remain in that range.

Amerant targets 2Q26 expenses of $68–$69 million, aiming to stabilize near $68 million and work toward an efficiency ratio of about 60%. Capital levels remain strong, and the company highlights improved credit monitoring, reduced criticized loans, and growing international deposits, particularly linked to Venezuelan market activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Amerant Bancorp Inc. appointed Carlos Iafigliola as President and Chief Executive Officer of both Amerant Bancorp Inc. and Amerant Bank, N.A., effective May 18, 2026. He had served as Interim CEO since November 2025 and previously held senior roles including Chief Operating Officer and Chief Financial Officer.

The Board completed a comprehensive executive search that considered internal and external candidates before confirming his permanent appointment. His compensation terms as President and CEO are not yet determined; until approved by the Compensation Committee, his pay remains as previously disclosed. Amerant also issued a press release describing his background and the Board’s support for his leadership and strategic roadmap.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.62%
Tags
current report
-
Rhea-AI Summary

Amerant Bancorp Inc. executive Armando Fleitas reported routine equity compensation activity involving Class A Common Stock. On May 11, 2026, 834 Restricted Stock Units vested and were converted into an equal number of Class A shares. In connection with this vesting, 204 shares were surrendered to cover tax withholding obligations at a price of $23.09 per share. Following these transactions, Fleitas directly owned 9,850.74 Class A shares. The RSUs were part of a 2,500-unit award granted in May 2023 that vests in three annual installments, contingent on continued service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amerant Bancorp Inc. director Odilon Almeida exercised restricted stock units into common shares as part of his equity compensation. He converted 3,761 RSUs, each economically equivalent to one share of Class A Common Stock, into 3,761 shares at a stated price of $0.00 per share. Following this vesting and conversion, his direct holdings of Class A Common Stock increased to 9,077 shares. The RSUs were granted previously and vest after one year of continuous service as a director, making this a routine compensation-related transaction rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amerant Bancorp Inc. director Dana Pamella J exercised restricted stock units into common shares as part of her equity compensation. She converted 3,761 restricted stock units into 3,761 shares of Class A Common Stock at a stated price of $0.00 per share. After this non-market, compensation-related transaction, she directly holds 27,524 Class A Common shares. Each RSU is the economic equivalent of one Class A share and was originally granted in an award scheduled to vest on the first anniversary of its grant date, contingent on continued service as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amerant Bancorp Inc. director Erin D. Knight exercised restricted stock units into common shares. On May 7, 2026, Knight converted 3,761 RSUs into 3,761 shares of Class A Common Stock at a reported price of $0.00 per share, reflecting a vesting-related equity award rather than an open-market purchase.

Following this transaction, Knight directly holds 10,007 shares of Class A Common Stock. Footnotes explain that each RSU is economically equivalent to one common share and that a prior RSU grant of 3,761 units vests on the first anniversary of its grant date, subject to continuous service as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amerant Bancorp Inc. director Lisa Lutoff-Perlo exercised equity awards to receive additional common shares. On May 7, 2026, she converted 3,761 Restricted Stock Units into 3,761 shares of Class A Common Stock at a price of $0.00 per share. Following this compensation-related transaction, she directly owns 4,261 shares of Amerant Bancorp Class A Common Stock. Footnotes state each RSU is economically equivalent to one common share and that the 3,761 RSUs were granted on May 7, 2025 and vested on the first anniversary, triggering delivery of the underlying shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amerant Bancorp Inc. director Gustavo M. Marturet exercised restricted stock units into common shares. On May 7, 2026, he converted 3,761 restricted stock units, each economically equivalent to one share of Class A Common Stock, into 3,761 Class A shares at a stated price of $0.00 per share. After this exercise, his direct holding of Class A Common Stock increased to 12,013 shares. The filing also lists significant indirect holdings, including 612,443 shares held by an Irrevocable Florida Trust for GAMM and 70,657 shares held by certain trusts and companies under common control for Marturet family members. The transactions reflect equity compensation vesting and do not include any open-market purchases or sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amerant Bancorp Inc. director Ashaki Rucker exercised restricted stock units into shares of Class A Common Stock. On this transaction date, 3,761 RSUs converted into 3,761 common shares, reflecting vesting of a prior equity award. Following the settlement, Rucker directly owns 9,991 Class A Common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amerant Bancorp Inc. director John Walton Quill exercised restricted stock units into Class A Common Stock. On May 7, 2026, he acquired 3,761 shares through the conversion of 3,761 RSUs that had represented the right to receive one share each.

These RSUs were originally granted on May 7, 2025 and were scheduled to vest on the first anniversary of the grant, contingent on continued board service. Following the exercise, Quill holds 21,079 shares of Class A Common Stock directly, with no remaining RSUs from this grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Amerant Bancorp (AMTB) SEC filings are available on StockTitan?

StockTitan tracks 74 SEC filings for Amerant Bancorp (AMTB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Amerant Bancorp (AMTB)?

The most recent SEC filing for Amerant Bancorp (AMTB) was filed on May 26, 2026.